BDBM502312 US11028090, Example 200

SMILES Cc1nnc2c(NCCCCNC(=O)OC(C)(C)C)nc3cc(ccc3n12)C(O)=O

InChI Key InChIKey=WGLHMIASSDPWJW-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 502312   

TargetBromodomain-containing protein 4(Human)
Korea Research Institute of Chemical Technology

Curated by ChEMBL
LigandPNGBDBM502312(US11028090, Example 200)
Affinity DataKd:  36nMAssay Description:Binding affinity to human BRD4 BD1 expressed in Escherichia coli BL21 (DE3) assessed as dissociation constant by bromodomain analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Korea Research Institute of Chemical Technology

Curated by ChEMBL
LigandPNGBDBM502312(US11028090, Example 200)
Affinity DataIC50: 71nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
US Patent

TargetBromodomain-containing protein 4(Human)
Korea Research Institute of Chemical Technology

Curated by ChEMBL
LigandPNGBDBM502312(US11028090, Example 200)
Affinity DataKd:  220nMAssay Description:Binding affinity to human BRD4 BD2 expressed in Escherichia coli BL21 (DE3) assessed as dissociation constant by bromodomain analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed